Bill
HB 1963
ARPNs may substitute a therapeutically equivalent stimulant for a physician-initiated prescription if criteria are met, and must notify the original prescribing physician.
Note on source materials: The materials supplied include inconsistent metadata (a title referencing Panola County jail and also an Illinois appropriation bill). This summary focuses on the bill text actually appended (Arkansas House Bill 1963, as engrossed S4/9/25), which amends Arkansas Code § 17-87-310 to clarify prescriptive authority for advanced practice registered nurses (APRNs) regarding stimulant medications. The Arkansas bill was approved by the Governor (Act 963) in April 2025.
Purpose and intent
- To clarify that an advanced practice registered nurse (APRN) who issues a prescription for a stimulant may substitute a therapeutically equivalent medication originally prescribed by a physician, and to set related procedural requirements.
Key provisions
- Amends Arkansas Code § 17-87-310(b)(2)(B)(ii) regarding APRN prescriptive authority for stimulants.
- Defines criteria for APRN prescribing of stimulants:
- The original prescription for the stimulant must have been initiated by a physician.
- The physician must have evaluated the patient within six (6) months before the APRN issues a prescription.
- The APRN’s prescription must be to treat the same condition as the original physician-initiated prescription.
- Adds explicit authorization allowing an APRN to substitute a therapeutically equivalent medication for the stimulant that the physician originally prescribed.
- Requires the APRN to notify the physician who originally prescribed the stimulant if the APRN substitutes a therapeutically equivalent medication.
Who is affected
- Advanced Practice Registered Nurses: receive clarified authority to substitute therapeutically equivalent stimulant medications under the specified conditions and are subject to a notification requirement to the original prescribing physician.
- Physicians: must be aware that an APRN may substitute equivalent stimulants and will receive notification when that happens if substitution occurs.
- Patients prescribed stimulant medications: may receive therapeutically equivalent alternatives under APRN care without needing a new physician-initiated prescription, provided statutory conditions are met.
- Pharmacies and employers/insurers may see operational effects when substitutions occur and notifications are sent.
Procedural / timeline notes
- Bill progressed through the 95th General Assembly (engrossed S4/9/25), received a Senate amendment requiring the physician notification, was passed and enrolled, transmitted to the Governor, and approved (notification as Act 963 in April 2025).
- The statutory amendment applies to controlled-prescribing processes already governed by Arkansas law; no separate appropriations or effective date beyond standard enactment timing are specified in the supplied text.
Practical impact
- Clarifies scope of APRN autonomy in managing stimulant therapy while preserving physician oversight through the six‑month evaluation requirement and a notification duty when therapeutic substitutions occur. This aims to streamline continuity of care while maintaining communication between APRNs and physicians.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
